虚血再灌流障害の世界市場2020年：企業別、地域別、種類・用途別

• レポートコード：MRC2012B0595
• 出版社/出版日：GlobalInfoResearch / 2020年12月21日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、122ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートでは、虚血再灌流障害の世界市場を広く調査・分析し、今後の市場展望をまとめております。虚血再灌流障害の種類別市場規模（フェーズ1、フェーズ2、前臨床）、用途別市場規模（心臓損傷、腎臓損傷、腸損傷、その他の損傷）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Angion Biomedica、Corline Biomedical、Opsona Therapeutics、Catalyst Biosciences、Bolder Biotechnology、Ischemix Inc、Balmes Transplantation、TheraSource、Pharming、Mifcortx、SBI Pharmaceuticals、NovelMed Therapeutics、Prothix、Hope Pharmaceuticals、Omeros Corp、
・地域別グローバル市場分析 2015年-2020年
・虚血再灌流障害の北米市場（アメリカ、カナダ、メキシコ）
・虚血再灌流障害のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）
・虚血再灌流障害のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア）
・虚血再灌流障害の南米市場（ブラジル、アルゼンチン）
・虚血再灌流障害の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ）
・種類別分析：フェーズ1、フェーズ2、前臨床
・用途別分析：心臓損傷、腎臓損傷、腸損傷、その他の損傷
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Ischemia Reperfusion Injury market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Ischemia Reperfusion Injury market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Ischemia Reperfusion Injury market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Ischemia Reperfusion Injury market has been segmented into:
Phase 1
Phase 2
Preclinical

By Application, Ischemia Reperfusion Injury has been segmented into:
Heart Injury
Kidney Injury
Intestine Injury
Other Injury

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ischemia Reperfusion Injury market presented in the report. This section sheds light on the sales growth of different regional and country-level Ischemia Reperfusion Injury markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ischemia Reperfusion Injury market.

The report offers in-depth assessment of the growth and other aspects of the Ischemia Reperfusion Injury market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Ischemia Reperfusion Injury Market Share Analysis
Ischemia Reperfusion Injury competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ischemia Reperfusion Injury sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ischemia Reperfusion Injury sales, revenue and market share for each player covered in this report.

The major players covered in Ischemia Reperfusion Injury are:
Angion Biomedica
Corline Biomedical
Opsona Therapeutics
Catalyst Biosciences
Bolder Biotechnology
Ischemix Inc
Balmes Transplantation
TheraSource
Pharming
Mifcortx
SBI Pharmaceuticals
NovelMed Therapeutics
Prothix
Hope Pharmaceuticals
Omeros Corp
Among other players domestic and global, Ischemia Reperfusion Injury market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Ischemia Reperfusion Injury Market Overview
1.1 Product Overview and Scope of Ischemia Reperfusion Injury
1.2 Classification of Ischemia Reperfusion Injury by Type
1.2.1 Global Ischemia Reperfusion Injury Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Ischemia Reperfusion Injury Revenue Market Share by Type in 2019
1.2.3 Phase 1
1.2.4 Phase 2
1.2.5 Preclinical
1.3 Global Ischemia Reperfusion Injury Market by Application
1.3.1 Overview: Global Ischemia Reperfusion Injury Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Heart Injury
1.3.3 Kidney Injury
1.3.4 Intestine Injury
1.3.5 Other Injury
1.4 Global Ischemia Reperfusion Injury Market by Regions
1.4.1 Global Ischemia Reperfusion Injury Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Ischemia Reperfusion Injury (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Ischemia Reperfusion Injury Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Ischemia Reperfusion Injury Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ischemia Reperfusion Injury Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Ischemia Reperfusion Injury Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ischemia Reperfusion Injury Status and Prospect (2015-2025)
2 Company Profiles
2.1 Angion Biomedica
2.1.1 Angion Biomedica Details
2.1.2 Angion Biomedica Major Business
2.1.3 Angion Biomedica SWOT Analysis
2.1.4 Angion Biomedica Product and Services
2.1.5 Angion Biomedica Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.2 Corline Biomedical
2.2.1 Corline Biomedical Details
2.2.2 Corline Biomedical Major Business
2.2.3 Corline Biomedical SWOT Analysis
2.2.4 Corline Biomedical Product and Services
2.2.5 Corline Biomedical Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.3 Opsona Therapeutics
2.3.1 Opsona Therapeutics Details
2.3.2 Opsona Therapeutics Major Business
2.3.3 Opsona Therapeutics SWOT Analysis
2.3.4 Opsona Therapeutics Product and Services
2.3.5 Opsona Therapeutics Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.4 Catalyst Biosciences
2.4.1 Catalyst Biosciences Details
2.4.2 Catalyst Biosciences Major Business
2.4.3 Catalyst Biosciences SWOT Analysis
2.4.4 Catalyst Biosciences Product and Services
2.4.5 Catalyst Biosciences Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bolder Biotechnology
2.5.1 Bolder Biotechnology Details
2.5.2 Bolder Biotechnology Major Business
2.5.3 Bolder Biotechnology SWOT Analysis
2.5.4 Bolder Biotechnology Product and Services
2.5.5 Bolder Biotechnology Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.6 Ischemix Inc
2.6.1 Ischemix Inc Details
2.6.2 Ischemix Inc Major Business
2.6.3 Ischemix Inc Product and Services
2.6.4 Ischemix Inc Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.7 Balmes Transplantation
2.7.1 Balmes Transplantation Details
2.7.2 Balmes Transplantation Major Business
2.7.3 Balmes Transplantation Product and Services
2.7.4 Balmes Transplantation Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.8 TheraSource
2.8.1 TheraSource Details
2.8.2 TheraSource Major Business
2.8.3 TheraSource Product and Services
2.8.4 TheraSource Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pharming
2.9.1 Pharming Details
2.9.2 Pharming Major Business
2.9.3 Pharming Product and Services
2.9.4 Pharming Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mifcortx
2.10.1 Mifcortx Details
2.10.2 Mifcortx Major Business
2.10.3 Mifcortx Product and Services
2.10.4 Mifcortx Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.11 SBI Pharmaceuticals
2.11.1 SBI Pharmaceuticals Details
2.11.2 SBI Pharmaceuticals Major Business
2.11.3 SBI Pharmaceuticals Product and Services
2.11.4 SBI Pharmaceuticals Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.12 NovelMed Therapeutics
2.12.1 NovelMed Therapeutics Details
2.12.2 NovelMed Therapeutics Major Business
2.12.3 NovelMed Therapeutics Product and Services
2.12.4 NovelMed Therapeutics Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.13 Prothix
2.13.1 Prothix Details
2.13.2 Prothix Major Business
2.13.3 Prothix Product and Services
2.13.4 Prothix Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.14 Hope Pharmaceuticals
2.14.1 Hope Pharmaceuticals Details
2.14.2 Hope Pharmaceuticals Major Business
2.14.3 Hope Pharmaceuticals Product and Services
2.14.4 Hope Pharmaceuticals Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
2.15 Omeros Corp
2.15.1 Omeros Corp Details
2.15.2 Omeros Corp Major Business
2.15.3 Omeros Corp Product and Services
2.15.4 Omeros Corp Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Ischemia Reperfusion Injury Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Ischemia Reperfusion Injury Players Market Share
3.2.2 Top 10 Ischemia Reperfusion Injury Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Ischemia Reperfusion Injury Revenue and Market Share by Regions
4.2 North America Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
4.3 Europe Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
4.5 South America Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
5 North America Ischemia Reperfusion Injury Revenue by Countries
5.1 North America Ischemia Reperfusion Injury Revenue by Countries (2015-2020)
5.2 USA Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
5.3 Canada Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
5.4 Mexico Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
6 Europe Ischemia Reperfusion Injury Revenue by Countries
6.1 Europe Ischemia Reperfusion Injury Revenue by Countries (2015-2020)
6.2 Germany Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
6.3 UK Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
6.4 France Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
6.5 Russia Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
6.6 Italy Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Ischemia Reperfusion Injury Revenue by Countries
7.1 Asia-Pacific Ischemia Reperfusion Injury Revenue by Countries (2015-2020)
7.2 China Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
7.3 Japan Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
7.4 Korea Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
7.5 India Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
8 South America Ischemia Reperfusion Injury Revenue by Countries
8.1 South America Ischemia Reperfusion Injury Revenue by Countries (2015-2020)
8.2 Brazil Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
8.3 Argentina Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Ischemia Reperfusion Injury by Countries
9.1 Middle East & Africa Ischemia Reperfusion Injury Revenue by Countries (2015-2020)
9.2 Saudi Arabia Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
9.3 UAE Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
9.4 Egypt Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
9.5 South Africa Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Ischemia Reperfusion Injury Revenue and Market Share by Type (2015-2020)
10.2 Global Ischemia Reperfusion Injury Market Forecast by Type (2019-2024)
10.3 Phase 1 Revenue Growth Rate (2015-2025)
10.4 Phase 2 Revenue Growth Rate (2015-2025)
10.5 Preclinical Revenue Growth Rate (2015-2025)
11 Global Ischemia Reperfusion Injury Market Segment by Application
11.1 Global Ischemia Reperfusion Injury Revenue Market Share by Application (2015-2020)
11.2 Ischemia Reperfusion Injury Market Forecast by Application (2019-2024)
11.3 Heart Injury Revenue Growth (2015-2020)
11.4 Kidney Injury Revenue Growth (2015-2020)
11.5 Intestine Injury Revenue Growth (2015-2020)
11.6 Other Injury Revenue Growth (2015-2020)
12 Global Ischemia Reperfusion Injury Market Size Forecast (2021-2025)
12.1 Global Ischemia Reperfusion Injury Market Size Forecast (2021-2025)
12.2 Global Ischemia Reperfusion Injury Market Forecast by Regions (2021-2025)
12.3 North America Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
12.4 Europe Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
12.6 South America Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Ischemia Reperfusion Injury Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ischemia Reperfusion Injury by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ischemia Reperfusion Injury Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Ischemia Reperfusion Injury Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Ischemia Reperfusion Injury Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Angion Biomedica Corporate Information, Location and Competitors
Table 7. Angion Biomedica Ischemia Reperfusion Injury Major Business
Table 8. Angion Biomedica Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 9. Angion Biomedica SWOT Analysis
Table 10. Angion Biomedica Ischemia Reperfusion Injury Product and Solutions
Table 11. Angion Biomedica Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Corline Biomedical Corporate Information, Location and Competitors
Table 13. Corline Biomedical Ischemia Reperfusion Injury Major Business
Table 14. Corline Biomedical Ischemia Reperfusion Injury Total Revenue (USD Million) (2018-2019)
Table 15. Corline Biomedical SWOT Analysis
Table 16. Corline Biomedical Ischemia Reperfusion Injury Product and Solutions
Table 17. Corline Biomedical Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Opsona Therapeutics Corporate Information, Location and Competitors
Table 19. Opsona Therapeutics Ischemia Reperfusion Injury Major Business
Table 20. Opsona Therapeutics Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 21. Opsona Therapeutics SWOT Analysis
Table 22. Opsona Therapeutics Ischemia Reperfusion Injury Product and Solutions
Table 23. Opsona Therapeutics Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Catalyst Biosciences Corporate Information, Location and Competitors
Table 25. Catalyst Biosciences Ischemia Reperfusion Injury Major Business
Table 26. Catalyst Biosciences Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 27. Catalyst Biosciences SWOT Analysis
Table 28. Catalyst Biosciences Ischemia Reperfusion Injury Product and Solutions
Table 29. Catalyst Biosciences Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Bolder Biotechnology Corporate Information, Location and Competitors
Table 31. Bolder Biotechnology Ischemia Reperfusion Injury Major Business
Table 32. Bolder Biotechnology Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 33. Bolder Biotechnology SWOT Analysis
Table 34. Bolder Biotechnology Ischemia Reperfusion Injury Product and Solutions
Table 35. Bolder Biotechnology Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Ischemix Inc Corporate Information, Location and Competitors
Table 37. Ischemix Inc Ischemia Reperfusion Injury Major Business
Table 38. Ischemix Inc Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 39. Ischemix Inc SWOT Analysis
Table 40. Ischemix Inc Ischemia Reperfusion Injury Product and Solutions
Table 41. Ischemix Inc Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Balmes Transplantation Corporate Information, Location and Competitors
Table 43. Balmes Transplantation Ischemia Reperfusion Injury Major Business
Table 44. Balmes Transplantation Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 45. Balmes Transplantation SWOT Analysis
Table 46. Balmes Transplantation Ischemia Reperfusion Injury Product and Solutions
Table 47. Balmes Transplantation Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. TheraSource Corporate Information, Location and Competitors
Table 49. TheraSource Ischemia Reperfusion Injury Major Business
Table 50. TheraSource Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 51. TheraSource SWOT Analysis
Table 52. TheraSource Ischemia Reperfusion Injury Product and Solutions
Table 53. TheraSource Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Pharming Corporate Information, Location and Competitors
Table 55. Pharming Ischemia Reperfusion Injury Major Business
Table 56. Pharming Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 57. Pharming SWOT Analysis
Table 58. Pharming Ischemia Reperfusion Injury Product and Solutions
Table 59. Pharming Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Mifcortx Corporate Information, Location and Competitors
Table 61. Mifcortx Ischemia Reperfusion Injury Major Business
Table 62. Mifcortx Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 63. Mifcortx SWOT Analysis
Table 64. Mifcortx Ischemia Reperfusion Injury Product and Solutions
Table 65. Mifcortx Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. SBI Pharmaceuticals Corporate Information, Location and Competitors
Table 67. SBI Pharmaceuticals Ischemia Reperfusion Injury Major Business
Table 68. SBI Pharmaceuticals Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 69. SBI Pharmaceuticals SWOT Analysis
Table 70. SBI Pharmaceuticals Ischemia Reperfusion Injury Product and Solutions
Table 71. SBI Pharmaceuticals Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. NovelMed Therapeutics Corporate Information, Location and Competitors
Table 73. NovelMed Therapeutics Ischemia Reperfusion Injury Major Business
Table 74. NovelMed Therapeutics Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 75. NovelMed Therapeutics SWOT Analysis
Table 76. NovelMed Therapeutics Ischemia Reperfusion Injury Product and Solutions
Table 77. NovelMed Therapeutics Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Prothix Corporate Information, Location and Competitors
Table 79. Prothix Ischemia Reperfusion Injury Major Business
Table 80. Prothix Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 81. Prothix SWOT Analysis
Table 82. Prothix Ischemia Reperfusion Injury Product and Solutions
Table 83. Prothix Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Hope Pharmaceuticals Corporate Information, Location and Competitors
Table 85. Hope Pharmaceuticals Ischemia Reperfusion Injury Major Business
Table 86. Hope Pharmaceuticals Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 87. Hope Pharmaceuticals SWOT Analysis
Table 88. Hope Pharmaceuticals Ischemia Reperfusion Injury Product and Solutions
Table 89. Hope Pharmaceuticals Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Omeros Corp Corporate Information, Location and Competitors
Table 91. Omeros Corp Ischemia Reperfusion Injury Major Business
Table 92. Omeros Corp Ischemia Reperfusion Injury Total Revenue (USD Million) (2017-2018)
Table 93. Omeros Corp SWOT Analysis
Table 94. Omeros Corp Ischemia Reperfusion Injury Product and Solutions
Table 95. Omeros Corp Ischemia Reperfusion Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Ischemia Reperfusion Injury Revenue (Million USD) by Players (2015-2020)
Table 97. Global Ischemia Reperfusion Injury Revenue Share by Players (2015-2020)
Table 98. Global Ischemia Reperfusion Injury Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Ischemia Reperfusion Injury Revenue Market Share by Regions (2015-2020)
Table 100. North America Ischemia Reperfusion Injury Revenue by Countries (2015-2020)
Table 101. North America Ischemia Reperfusion Injury Revenue Market Share by Countries (2015-2020)
Table 102. Europe Ischemia Reperfusion Injury Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Ischemia Reperfusion Injury Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Ischemia Reperfusion Injury Revenue by Countries (2015-2020)
Table 105. South America Ischemia Reperfusion Injury Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Ischemia Reperfusion Injury Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Ischemia Reperfusion Injury Revenue Market Share by Countries (2015-2020)
Table 108. Global Ischemia Reperfusion Injury Revenue (Million USD) by Type (2015-2020)
Table 109. Global Ischemia Reperfusion Injury Revenue Share by Type (2015-2020)
Table 110. Global Ischemia Reperfusion Injury Revenue Forecast by Type (2021-2025)
Table 111. Global Ischemia Reperfusion Injury Revenue by Application (2015-2020)
Table 112. Global Ischemia Reperfusion Injury Revenue Share by Application (2015-2020)
Table 113. Global Ischemia Reperfusion Injury Revenue Forecast by Application (2021-2025)
Table 114. Global Ischemia Reperfusion Injury Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Ischemia Reperfusion Injury Picture
Figure 2. Global Ischemia Reperfusion Injury Revenue Market Share by Type in 2019
Figure 3. Phase 1 Picture
Figure 4. Phase 2 Picture
Figure 5. Preclinical Picture
Figure 6. Ischemia Reperfusion Injury Revenue Market Share by Application in 2019
Figure 7. Heart Injury Picture
Figure 8. Kidney Injury Picture
Figure 9. Intestine Injury Picture
Figure 10. Other Injury Picture
Figure 11. Global Ischemia Reperfusion Injury Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Ischemia Reperfusion Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Ischemia Reperfusion Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Ischemia Reperfusion Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Ischemia Reperfusion Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Ischemia Reperfusion Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Ischemia Reperfusion Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Ischemia Reperfusion Injury Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Ischemia Reperfusion Injury Revenue Market Share in 2019
Figure 20. Global Top 10 Players Ischemia Reperfusion Injury Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Ischemia Reperfusion Injury Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Ischemia Reperfusion Injury Revenue Market Share by Regions (2015-2020)
Figure 24. Global Ischemia Reperfusion Injury Revenue Market Share by Regions in 2018
Figure 25. North America Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 26. Europe Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 28. South America Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 30. North America Ischemia Reperfusion Injury Revenue Market Share by Countries (2015-2020)
Figure 31. North America Ischemia Reperfusion Injury Revenue Market Share by Countries in 2019
Figure 32. USA Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 33. Canada Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 35. Europe Ischemia Reperfusion Injury Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Ischemia Reperfusion Injury Revenue Market Share by Countries in 2019
Figure 37. Germany Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 38. UK Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 39. France Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 40. Russia Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 41. Italy Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Ischemia Reperfusion Injury Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Ischemia Reperfusion Injury Revenue Market Share by Countries in 2019
Figure 44. China Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 45. Japan Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 46. Korea Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 47. India Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 49. South America Ischemia Reperfusion Injury Revenue Market Share by Countries (2015-2020)
Figure 50. South America Ischemia Reperfusion Injury Revenue Market Share by Countries in 2019
Figure 51. Brazil Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Ischemia Reperfusion Injury Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Ischemia Reperfusion Injury Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 56. UAE Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Ischemia Reperfusion Injury Revenue and Growth Rate (2015-2020)
Figure 59. Global Ischemia Reperfusion Injury Revenue Share by Type (2015-2020)
Figure 60. Global Ischemia Reperfusion Injury Revenue Share by Type in 2019
Figure 61. Global Ischemia Reperfusion Injury Market Share Forecast by Type (2021-2025)
Figure 62. Global Phase 1 Revenue Growth Rate (2015-2020)
Figure 63. Global Phase 2 Revenue Growth Rate (2015-2020)
Figure 64. Global Preclinical Revenue Growth Rate (2015-2020)
Figure 65. Global Ischemia Reperfusion Injury Revenue Share by Application (2015-2020)
Figure 66. Global Ischemia Reperfusion Injury Revenue Share by Application in 2019
Figure 67. Global Ischemia Reperfusion Injury Market Share Forecast by Application (2021-2025)
Figure 68. Global Heart Injury Revenue Growth Rate (2015-2020)
Figure 69. Global Kidney Injury Revenue Growth Rate (2015-2020)
Figure 70. Global Intestine Injury Revenue Growth Rate (2015-2020)
Figure 71. Global Other Injury Revenue Growth Rate (2015-2020)
Figure 72. Global Ischemia Reperfusion Injury Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Ischemia Reperfusion Injury Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Ischemia Reperfusion Injury Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
Figure 76. Europe Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
Figure 78. South America Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Ischemia Reperfusion Injury Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

以下、関連資料のご紹介

心筋虚血治療の世界市場（～2026年）

Global Myocardial Ischemia Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03887 2020年11月20日 93Pages
当調査資料は心筋虚血治療のグローバル市場について調査・分析したレポートです。種類別（医薬品、手術、その他）市場規模、用途別（病院、診療所、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

外傷性脳損傷診断の世界市場2020年：企業別、地域別、種類・用途別

MRC2012B1578 2020年12月28日 103Pages
本調査レポートでは、外傷性脳損傷診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。外傷性脳損傷診断の種類別市場規模（消耗品、機器、その他）、用途別市場規模（軍事用、民間用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場...

急性脊髄損傷の世界市場（～2026年）

Global Acute Spinal Cord Injury Market Size, Status and Forecast 2020-2026
MRC2-11QY13571 2020年11月30日 93Pages
当調査資料は急性脊髄損傷のグローバル市場について調査・分析したレポートです。種類別（実験室検査、画像検査）市場規模、用途別（病院、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メ...

重症虚血肢（CLI）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別

Global Critical Limb Ischemia Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
MRC2012A2487 2020年12月21日 108Pages
本調査レポートでは、重症虚血肢（CLI）治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。重症虚血肢（CLI）治療薬の種類別市場規模（HC-016、JVS-100、NFx-101、NK-104 NP、その他）、用途別市場規模（病院、在宅医療、ASC）、地域別市場規模（北米、アメリ...

心筋虚血治療薬の世界市場（～2026年）

Global Myocardial Ischemia Drugs Market Insights and Forecast to 2026
MRC2-11QY07954 2020年11月20日 110Pages
当調査資料は心筋虚血治療薬のグローバル市場について調査・分析したレポートです。種類別（BAY-606583、CMK-103、DT-010、ヒューマニン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

放射線障害治療薬の世界市場（～2026年）

Global Radiation Injury Drugs Market Insights and Forecast to 2026
MRC2-11QY14599 2020年11月30日 111Pages
当調査資料は放射線障害治療薬のグローバル市場について調査・分析したレポートです。種類別（Aerosurf、BMX-001、C-2E2、C-2E5、Des-Aspアンジオテンシン1、DG-3、その他）市場規模、用途別（ASC、病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...

クリティカルリム虚血治療薬の世界市場（～2026年）

Global Critical Limb Ischemia Drug Market Insights and Forecast to 2026
MRC2-11QY00746 2020年11月20日 117Pages
当調査資料はクリティカルリム虚血治療薬のグローバル市場について調査・分析したレポートです。種類別（HC-016、JVS-100、NFx-101、NK-104 NP、その他）市場規模、用途別（病院、在宅介護、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

神経リハビリテーションの世界市場2020年：企業別、地域別、種類・用途別

Global Neurorehabilitation Market 2020 by Company, Regions, Type and Application, Forecast to 2025
MRC2012B0873 2020年12月24日 101Pages
本調査レポートでは、神経リハビリテーションの世界市場を広く調査・分析し、今後の市場展望をまとめております。神経リハビリテーションの種類別市場規模（脳損傷、脊髄損傷、末梢神経損傷、その他）、用途別市場規模（総合病院、リハビリテーション専門病院、地域リハビリテーションセンター）、地域別市場規模（北米、ア...

白血球表面抗原CD47の世界市場（～2026年）

Global Leukocyte Surface Antigen CD47 Market Insights and Forecast to 2026
MRC2-11QY07177 2020年11月20日 117Pages
当調査資料は白血球表面抗原CD47のグローバル市場について調査・分析したレポートです。種類別（B-6H12、ALX-148、CC-90002、PSTx-23、その他）市場規模、用途別（リンパ腫、卵巣癌、虚血再灌流障害、腎臓移植拒絶反応、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...

プラズマ療法の世界市場2020年：企業別、地域別、種類・用途別

Global Plasma Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025
MRC2012B1013 2020年12月24日 105Pages
本調査レポートでは、プラズマ療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。プラズマ療法の種類別市場規模（純粋PRP、白血球豊富PRP、白血球豊富フィブリン（L-PRF））、用途別市場規模（整形外科、皮膚科、心筋損傷、歯科、神経損傷）、地域別市場規模（北米、アメリカ、ヨーロッパ、...

心筋虚血治療の世界市場（～2026年） Myocardial ischemia is a condition characterized by insufficient blood flow to the heart creating a paucity of oxygen leading to heart attacks. It is also known as cardiac ischemia and the blockage of coronary artery can cause abnormal heart rhythms. The Americas are the flag-bearer, the region is g…
急性脊髄損傷の世界市場（～2026年） Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children. The treatment of acute spinal cord injury is dependent on few f…
心筋虚血治療薬の世界市場（～2026年） Market Analysis and Insights: Global Myocardial Ischemia Drugs Market The global Myocardial Ischemia Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Myocardial Ischemia Drugs Scope and Market Size Myocardial Isch…
外傷性脳損傷診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Traumatic Brain Injury Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
放射線障害治療薬の世界市場（～2026年） Market Analysis and Insights: Global Radiation Injury Drugs Market The global Radiation Injury Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Radiation Injury Drugs Scope and Market Size Radiation Injury Drugs m…